Thyrocare Technologies has released its unaudited financial results for the quarter ended June 30, 2025, following approval by its board of directors. On a consolidated basis, total income from operations reached 193.03 Cr, with net profit after tax at 38.29 Cr. Consolidated diluted earnings per share stood at 7.33. For standalone results, total income was 178.89 Cr, and net profit after tax was 36.05 Cr, with diluted EPS at 6.78. These results offer key insights into the company's recent performance.